Learning Objectives:
- Review the biology and classification of DLBCL
- Highlight the current treatment paradigm in DLBCL and areas of need
- Discuss a phase I/II clinical trial of lenalidomide and EPOCH-R in MYC-associated DLBCL
Session date:
10/24/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Kirk Cahill, MD